Sign up for email alerts
Developing Innovative Solutions to Treat Infectious Disease and Acute Illnesses
Investors
News Releases
- Durata Therapeutics to Present at Jefferies 2013 Global Healthcare Conference
May 29, 2013, 7:30 AM EDT - Paul A. Friedman, M.D. is Elected to Durata Therapeutics' Board of Directors
May 16, 2013, 1:44 PM EDT - Durata Therapeutics, Inc. Reports First Quarter 2013 Financial Results
May 9, 2013, 7:00 AM EDT - Durata Therapeutics to Present at Bank of America Merrill Lynch 2013 Healthcare Conference
May 7, 2013, 7:30 AM EDT - Durata Therapeutics to Announce First Quarter 2013 Financial Results on May 9, 2013
May 2, 2013, 7:30 AM EDT - Phase I Data Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Weekly Doses of Dalbavancin Presented at the 23rd Annual ECCMID Meeting
Apr 29, 2013, 7:30 AM EDT - New Data Demonstrating In Vitro Potency of Dalbavancin Against Bacterial Pathogens Presented at the 23rd Annual ECCMID Meeting
Apr 29, 2013, 7:30 AM EDT - Durata Therapeutics to Present Two Dalbavancin Posters at the 23rd Annual ECCMID Meeting
Apr 24, 2013, 7:30 AM EDT - Durata Therapeutics to Present at the 2013 Needham Healthcare Conference
Apr 22, 2013, 3:30 PM EDT - Durata Therapeutics Closes Public Offering of Common Stock
Apr 17, 2013, 4:15 PM EDT
